{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:56Z","timestamp":1787022896378,"version":"build-2736575974"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:p>BACKGROUND. The QuantiFERON-TB Gold test was the first blood test to be approved for the diagnosis of latent tuberculosis infection. Although it has been shown to be sensitive and specific in adults, limited data on its performance in children are available.<\/jats:p>\n                  <jats:p>METHODS. This was a prospective study of children receiving health care in New York, New York. Each child was assessed for risk factors for Mycobacterium tuberculosis infection, underwent tuberculin skin testing, and had a QuantiFERON-TB Gold In-Tube test performed. The concordance between tuberculin skin test and QuantiFERON-TB Gold In-Tube test results was calculated, and the results were analyzed according to the likelihood of exposure to M tuberculosis.<\/jats:p>\n                  <jats:p>RESULTS. Data for 207 children with valid tuberculin skin test and QuantiFERON-TB Gold In-Tube test results were analyzed. There was excellent correlation between negative tuberculin skin test results and negative QuantiFERON-TB Gold In-Tube test results; however, only 23% of children with positive tuberculin skin test results had positive QuantiFERON-TB Gold In-Tube test results. Positive QuantiFERON-TB Gold In-Tube test results were associated with increased likelihood of M tuberculosis exposure, and interferon \u03b3 levels were higher in children with known recent exposure to M tuberculosis, compared with children with older exposure histories. Younger children produced lower interferon \u03b3 levels in response to the mitogen (phytohemagglutinin) control used in the QuantiFERON-TB Gold In-Tube test, but indeterminant results were low for children of all ages. Performance characteristics were similar across all age groups.<\/jats:p>\n                  <jats:p>CONCLUSION. The QuantiFERON-TB Gold In-Tube test is a specific test for M tuberculosis exposure in children, with performance characteristics similar to those for adults residing in regions with low levels of endemic disease. Concerns about test sensitivity, especially for children &amp;lt;2 years of age, will require additional prospective long-term evaluation.<\/jats:p>","DOI":"10.1542\/peds.2007-3618","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T10:58:03Z","timestamp":1230548283000},"page":"30-37","source":"Crossref","is-referenced-by-count":119,"title":["Latent Tuberculosis Diagnosis in Children by Using the QuantiFERON-TB Gold In-Tube Test"],"prefix":"10.1542","volume":"123","author":[{"given":"Jennifer","family":"Lighter","sequence":"first","affiliation":[{"name":"Saul Krugman Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Rigaud","sequence":"additional","affiliation":[{"name":"Saul Krugman Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Eduardo","sequence":"additional","affiliation":[{"name":"Saul Krugman Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hui","family":"Peng","sequence":"additional","affiliation":[{"name":"Saul Krugman Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Pollack","sequence":"additional","affiliation":[{"name":"Saul Krugman Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,1,1]]},"reference":[{"key":"2021120905101767800_R1","unstructured":"World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2002"},{"key":"2021120905101767800_R2","doi-asserted-by":"crossref","unstructured":"Marais B, Gie R, Schaaf HS, Beyers N, Donald P, Starke J. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med.\u20082006;173(10):1078\u20131090","DOI":"10.1164\/rccm.200511-1809SO"},{"key":"2021120905101767800_R3","unstructured":"Lewinsohn D, Gennaro M, Scholvinck D. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis.\u20082004;8(5):658\u2013674"},{"key":"2021120905101767800_R4","doi-asserted-by":"crossref","unstructured":"Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis.\u20081993;17(6):968\u2013975","DOI":"10.1093\/clinids\/17.6.968"},{"key":"2021120905101767800_R5","unstructured":"Farhat M, Greenwaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculoous mycobacteria. Int J Tuberc Lung Dis.\u20082006;10(11):1192\u20131204"},{"key":"2021120905101767800_R6","doi-asserted-by":"crossref","unstructured":"Mori T, Sakatani M, Yamagishi F, Takashima T. Specific detection of tuberculosis infection: an interferon \u03b3 based assay using new antigens. Am J Respir Crit Care Med.\u20082004;170(1):59\u201364","DOI":"10.1164\/rccm.200402-179OC"},{"key":"2021120905101767800_R7","unstructured":"Brock I, Munk ME, Kok-Jensen A, Anderson P. Performance of whole blood IFN-\u03b3 test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CRP-10. Int J Tuberc Lung Dis.\u20082001;5(5):462\u2013467"},{"key":"2021120905101767800_R8","doi-asserted-by":"crossref","unstructured":"Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-\u03b3 assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med.\u20082005;172(5):631\u2013635","DOI":"10.1164\/rccm.200502-196OC"},{"key":"2021120905101767800_R9","doi-asserted-by":"crossref","unstructured":"Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-\u03b3 release assays. Clin Infect Dis.\u20082007;45(7):826\u2013836","DOI":"10.1086\/521106"},{"key":"2021120905101767800_R10","doi-asserted-by":"crossref","unstructured":"Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-\u03b3 assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med.\u20082007;175(6):618\u2013627","DOI":"10.1164\/rccm.200608-1099OC"},{"key":"2021120905101767800_R11","unstructured":"Mazurek G, Jereb J, LoBue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection: United States. MMWR Recomm Rep.\u20082005;54(RR-15):49\u201355"},{"key":"2021120905101767800_R12","unstructured":"Harris TG, Dorsinville M, Munsiff, et al. Piloting of QuantiFERON-TB Gold by the New York City Department of Health and Mental Hygiene. Presented at the First Global Symposium on Interferon-\u03b3 Releasing Assays; February 21\u201322, 2007; Vancouver, Canada"},{"key":"2021120905101767800_R13","doi-asserted-by":"crossref","unstructured":"Starke JR. Use of new TB test in children should be limited. AAP News.\u20082006;27(3):14\u201315","DOI":"10.1542\/gr.15-2-14"},{"key":"2021120905101767800_R14","unstructured":"Centers for Disease Control and Prevention. Trends in tuberculosis incidence: United States, 2006. MMWR Morb Mortal Wkly Rep.\u20082007;56(11):245\u2013250"},{"key":"2021120905101767800_R15","doi-asserted-by":"crossref","unstructured":"Nakaoka H, Lawson L, Squire SB, et al. Risk for tuberculosis among children. Emerg Infect Dis.\u20082006;12(9):1383\u20131388","DOI":"10.3201\/eid1209.051606"},{"key":"2021120905101767800_R16","unstructured":"Tsiouris S, Austin J, Toro P, et al. Results of a tuberculosis-specific IFN-\u03b3 assay in children at high risk of tuberculosis infection. Int J Tuberc Lung Dis.\u20082006;10(8):939\u2013941"},{"key":"2021120905101767800_R17","doi-asserted-by":"crossref","unstructured":"Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-\u03b3 assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect.\u20082007;54(3):267\u2013276","DOI":"10.1016\/j.jinf.2006.04.007"},{"key":"2021120905101767800_R18","doi-asserted-by":"crossref","unstructured":"Detjen A, Keil T, Roll S, et al. Interferon-\u03b3 release assays improve the diagnosis of tuberculosis and nontuberculosus mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis.\u20082007;45(3):322\u2013328","DOI":"10.1086\/519266"},{"key":"2021120905101767800_R19","doi-asserted-by":"crossref","unstructured":"Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med.\u20082007;146(5):340\u2013354","DOI":"10.7326\/0003-4819-146-5-200703060-00006"},{"key":"2021120905101767800_R20","unstructured":"Arend S. A supersize contact investigation with comparison of two IGRA. Presented at the First Global Symposium on Interferon-\u03b3 Releasing Assays; February 21\u201322, 2007; Vancouver, Canada"},{"key":"2021120905101767800_R21","unstructured":"Mori T, Harada N, Higuchi K. Waning of the specific interferon-\u03b3 response after years of tuberculosis infection. Int J Tuberc Lung Dis.\u20082007;11(9):1021\u20131025"},{"key":"2021120905101767800_R22","doi-asserted-by":"crossref","unstructured":"Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM. Extended culture enhances sensitivity of \u03b3 interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol.\u20082007;14(6):796\u2013798","DOI":"10.1128\/CVI.00093-07"},{"key":"2021120905101767800_R23","doi-asserted-by":"crossref","unstructured":"Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific interferon-\u03b3 release assays using short versus prolonged in vitro incubation. Clin Vaccine Immunol.\u20082007;14(7):880\u2013885","DOI":"10.1128\/CVI.00132-07"},{"key":"2021120905101767800_R24","doi-asserted-by":"crossref","unstructured":"Connell TB, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon \u03b3 assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax.\u20082006;61(7):616\u2013620","DOI":"10.1136\/thx.2005.048033"},{"key":"2021120905101767800_R25","doi-asserted-by":"crossref","unstructured":"Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted?Trends Mol Med.\u20082007;13(5):175\u2013182","DOI":"10.1016\/j.molmed.2007.03.004"},{"key":"2021120905101767800_R26","doi-asserted-by":"crossref","unstructured":"Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG. Correlation of ESAT-6-specific \u03b3 interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun.\u20082002;70(6):3026\u20133032","DOI":"10.1128\/IAI.70.6.3026-3032.2002"},{"key":"2021120905101767800_R27","doi-asserted-by":"crossref","unstructured":"Buddle BM, Parlane NA, Keen DL, et al. Differentiation between Mycobacterium bovis BCG-vaccinated and M bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol.\u20081999;6(1):1\u20135","DOI":"10.1128\/CDLI.6.1.1-5.1999"},{"key":"2021120905101767800_R28","doi-asserted-by":"crossref","unstructured":"Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol.\u20082002;40(2):704\u2013706","DOI":"10.1128\/JCM.40.2.704-706.2002"},{"key":"2021120905101767800_R29","doi-asserted-by":"crossref","unstructured":"Demissie A, Abebe M, Aseffa A, et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4\u03b42. J Immunol.\u20082004;172(11):6938\u20136943","DOI":"10.4049\/jimmunol.172.11.6938"},{"key":"2021120905101767800_R30","doi-asserted-by":"crossref","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of whole-blood IFN-\u03b3 assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med.\u20082008;177(10):1164\u20131170","DOI":"10.1164\/rccm.200711-1613OC"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/1\/30\/1123517\/zpe00109000030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/1\/30\/1123517\/zpe00109000030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T17:26:43Z","timestamp":1639070803000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/1\/30\/71939\/Latent-Tuberculosis-Diagnosis-in-Children-by-Using"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1,1]]},"published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-3618","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}